UROV Message Board Post 9992170 | Urovant Sciences Ltd.
home / stock / urov / urov message board
campionator
(investorshub)
Posted on: Nov/15/2020 23:49:56
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159505613
When's the FDA approval?
News, Short Squeeze, Breakout and More Instantly...
Urovant Sciences Ltd. Company Name:
UROV Stock Symbol:
Market:
-
Interim 12-week analysis from a Phase 2a trial of the potential gene therapy, URO-902, in women with overactive bladder (OAB) and urge urinary incontinence (UUI) will be featured in a late breaker presentation by Kenneth M. Peters, M.D. during Friday morning’s plenary session...
-
Study showed clinically meaningful impact on common symptoms of overactive bladder (OAB) compared to placebo from baseline to week 12 Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd., today announced positive topline results from its Phase 2a, double-...
-
Data from the 12-week EMPOWUR trial regarding patient perceptions of improvement of OAB symptoms show that significantly more patients treated once-daily with GEMTESA ® (vibegron) experienced patient-perceived improvements due to the reduction in micturition frequency (urin...